Bob Proulx Discusses the Opportunity for MagSense™ Imaging

Watch Imagion CEO Bob Proulx discuss the opportunity for MagSense™ Imaging on Switzer's CEO Masterclass: https://youtu.be/kpJ0Lpwdk38 Today’s imaging…


Change of Registered Address

Imagion Biosystems Limited wishes to advise that its Australian registered office address has changed with immediate effect to: c/o K&L Gates, Level 25,…


Investor Presentation — Imagion Biosystems MagSense™ Technology

President and CEO Bob Proulx today addressed investors at the Switzer Small and Microcap Investor Day in Sydney Australia. He discussed recent milestones,…


Appendix 4E and 2019 Full Year Results

Appendix 4E and 2019 Full Year Results Key Developments Achieved for MagSense™ Imaging Technology Imagion Biosystems has released its Appendix 4E and…


Imagion to present at Switzer Small and Microcap Investor Day

Come along to Switzer Small & Micro Cap Investor Day Switzer Financial Group is pleased to bring you the Switzer Small & Micro Cap Investor Day on…


Business Update: Manufacturing Commences

Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to…


Oliver Steinbach, PhD, Appointed Vice President of Clinical and Regulatory Affairs

Imagion Biosystems announces the appointment of Oliver Steinbach, PhD, as Vice President of Clinical and Regulatory Affairs. Dr. Steinbach will serve as the…


Imagion Podcast Episode 2: Mike Harsh speaks with Marisa Zammit from WE Communications

Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion's technology could transform the imaging industry.…